advertisement

Baltimore Orioles and Texas Rangers meet in game 2 of series

Texas Rangers (37-41, third in the AL West) vs. Baltimore Orioles (37-44, fifth in the AL East)

Baltimore; Tuesday, 7:05 p.m. EDT

PITCHING PROBABLES: Rangers: Spencer Howard (0-0); Orioles: Austin Voth (0-1, 7.34 ERA, 1.89 WHIP, 30 strikeouts)

FANDUEL SPORTSBOOK LINE: Orioles -109, Rangers -109; over/under is 9 1/2 runs

BOTTOM LINE: The Baltimore Orioles face the Texas Rangers with a 1-0 series lead.

Baltimore has a 19-17 record at home and a 37-44 record overall. The Orioles rank eighth in the AL with 84 total home runs, averaging one per game.

Texas has a 37-41 record overall and a 20-21 record on the road. The Rangers are 27-7 in games when they have more hits than their opponents.

The teams meet Tuesday for the second time this season.

TOP PERFORMERS: Anthony Santander leads Baltimore with 15 home runs while slugging .426. Ryan Mountcastle is 10-for-39 with two home runs and three RBI over the past 10 games.

Adolis Garcia has 16 doubles, three triples and 15 home runs for the Rangers. Marcus Semien is 13-for-43 with two doubles and three home runs over the last 10 games.

LAST 10 GAMES: Orioles: 5-5, .214 batting average, 3.24 ERA, outscored opponents by six runs

Rangers: 4-6, .253 batting average, 3.41 ERA, outscored opponents by seven runs

INJURIES: Orioles: Kyle Bradish: 15-Day IL (shoulder), Alexander Wells: 60-Day IL (elbow), Chris Ellis: 60-Day IL (shoulder), John Means: 60-Day IL (elbow)

Rangers: Matt Bush: 15-Day IL (forearm), Eli White: 60-Day IL (wrist), Jonathan Hernandez: 60-Day IL (elbow)

___

The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.

Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.